Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingfei Xiaoyan Wan in acute and acute exacerbation of chronic bronchitis
CTR20192485Phase 2Active
- Sponsor
- Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.
- Start
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of Qingfei Xiaoyan Wan in acute bronchitis, chronic bronchitis (CB), sponsored by Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.. Started Dec 2019; status: active.
02
Drugs
Qingfei Xiaoyan Wan
03
Conditions
acute bronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20192485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192485.